Search Results - "Guhagarkar, Swati A"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Polyethylene sebacate–doxorubicin nanoparticles for hepatic targeting by Guhagarkar, Swati A., Gaikwad, Rajiv V., Samad, Abdul, Malshe, Vinod C., Devarajan, Padma V.

    Published in International journal of pharmaceutics (30-11-2010)
    “…The study presents a radically modified nanoprecipitation method for the design of polyethylene sebacate–doxorubicin nanoparticles with high drug loading for…”
    Get full text
    Journal Article
  2. 2

    Polyethylene Sebacate-Silymarin Nanoparticles with Enhanced Hepatoprotective Activity by Guhagarkar, Swati A, Shah, Devang, Patel, Mitesh D, Sathaye, Sadhana S, Devarajan, Padma V

    Published in Journal of nanoscience and nanotechnology (01-06-2015)
    “…The present study evaluates role of pullulan as hepatic targeting agent. Nanoparticles of silymarin (SIM) a hepatoprotective drug were prepared using…”
    Get more information
    Journal Article
  3. 3

    Nanoparticles of Polyethylene Sebacate: A New Biodegradable Polymer by Guhagarkar, Swati A., Malshe, Vinod C., Devarajan, Padma V.

    Published in AAPS PharmSciTech (01-09-2009)
    “…The present study demonstrates feasibility of preparation of nanoparticles using a novel polymer, polyethylene sebacate (PES), and its application in the…”
    Get full text
    Journal Article
  4. 4

    Engineered nanocarriers of doxorubicin: a current update by Patil, Rajesh R, Guhagarkar, Swati A, Devarajan, Padma V

    “…Doxorubicin remains the first line of treatment for various cancers ever since its discovery in 1971. Cardiotoxicity and nephrotoxicity associated with…”
    Get more information
    Journal Article
  5. 5

    Evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in Hep G2 cell line by Guhagarkar, Swati A., Majee, Sharmila B., Samad, Abdul, Devarajan, Padma V.

    Published in Cancer nanotechnology (2011)
    “…The present study discusses evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in the Hep G2 cell…”
    Get full text
    Journal Article